7qdt

From Proteopedia

(Difference between revisions)

Revision as of 11:06, 15 November 2023

Crystal structure of a mutant (P393GX) Thyroid Receptor Alpha ligand binding domain designed to model dominant negative human mutations.

Structural highlights

7qdt is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:	X-ray diffraction, Resolution 3Å
Ligands:
Resources:	FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Disease

THA_HUMAN Defects in THRA are the cause of congenital hypothyroidism non-goitrous type 6 (CHNG6) [MIM:614450. A disease characterized by growth retardation, developmental retardation, skeletal dysplasia, borderline low thyroxine levels and high triiodothyronine levels. There is differential sensitivity to thyroid hormone action, with retention of hormone responsiveness in the hypothalamic pituitary axis and liver but skeletal, gastrointestinal, and myocardial resistance.^[1]

Function

THA_HUMAN Nuclear hormone receptor. High affinity receptor for triiodothyronine.

Publication Abstract from PubMed

Mutations in thyroid hormone receptor alpha (TRalpha), a ligand-inducible transcription factor, cause Resistance to Thyroid Hormone alpha (RTHalpha). This disorder is characterised by tissue-specific hormone refractoriness and hypothyroidism, due to inhibition of target gene expression by mutant TRalpha-corepressor complexes. Using biophysical approaches, we show that RTHalpha-associated TRalpha mutants devoid of ligand-dependent transcription activation function, unexpectedly retain the ability to bind thyroid hormone. Visualisation of ligand (T3) within the crystal structure of a prototypic TRalpha mutant, validates this notion. This finding prompted synthesis of different thyroid hormone analogues, identifying a lead compound (ES08) which dissociates corepressor from mutant human TRalpha more efficaciously than T3. ES08 rescues developmental anomalies in a zebrafish model of RTHalpha and induces target gene expression in TRalpha mutation-containing cells from an RTHalpha patient, more effectively than T3. Our observations provide proof-of-principle for developing synthetic ligands that can relieve transcriptional repression by the mutant TRalpha-corepressor complex, for treatment of RTHalpha.

Structure-guided approach to relieving transcriptional repression inResistance to Thyroid Hormone alpha.,Romartinez-Alonso B, Agostini M, Jones H, McLellan J, Sood D, Tomkinson N, Marelli F, Gentile I, Visser WE, Schoenmakers E, Fairall L, Privalsky M, Moran C, Persani L, Chatterjee K, Schwabe J Mol Cell Biol. 2021 Dec 6:MCB0036321. doi: 10.1128/MCB.00363-21. PMID:34871063^[2]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

↑ Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K. A mutation in the thyroid hormone receptor alpha gene. N Engl J Med. 2012 Jan 19;366(3):243-9. doi: 10.1056/NEJMoa1110296. Epub 2011 Dec, 14. PMID:22168587 doi:10.1056/NEJMoa1110296
↑ Romartinez-Alonso B, Agostini M, Jones H, McLellan J, Sood D, Tomkinson N, Marelli F, Gentile I, Visser WE, Schoenmakers E, Fairall L, Privalsky M, Moran C, Persani L, Chatterjee K, Schwabe J. Structure-guided approach to relieving transcriptional repression inResistance to Thyroid Hormone alpha. Mol Cell Biol. 2021 Dec 6:MCB0036321. doi: 10.1128/MCB.00363-21. PMID:34871063 doi:http://dx.doi.org/10.1128/MCB.00363-21

1 Structural highlights
2 Disease
3 Function
4 Publication Abstract from PubMed
5 See Also
6 References

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/7qdt"

@@ Line 3: / Line 3: @@
 <StructureSection load='7qdt' size='340' side='right'caption='[[7qdt]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
 == Structural highlights ==
-<table><tr><td colspan='2'>[[7qdt]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7QDT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7QDT FirstGlance]. <br>
+<table><tr><td colspan='2'>[[7qdt]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7QDT OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7QDT FirstGlance]. <br>
-</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=T3:3,5,3TRIIODOTHYRONINE'>T3</scene></td></tr>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=T3:3,5,3TRIIODOTHYRONINE'>T3</scene></td></tr>
 <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7qdt FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7qdt OCA], [https://pdbe.org/7qdt PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7qdt RCSB], [https://www.ebi.ac.uk/pdbsum/7qdt PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7qdt ProSAT]</span></td></tr>
 </table>
 == Disease ==
-[[https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN]] Defects in THRA are the cause of congenital hypothyroidism non-goitrous type 6 (CHNG6) [MIM:[https://omim.org/entry/614450 614450]]. A disease characterized by growth retardation, developmental retardation, skeletal dysplasia, borderline low thyroxine levels and high triiodothyronine levels. There is differential sensitivity to thyroid hormone action, with retention of hormone responsiveness in the hypothalamic pituitary axis and liver but skeletal, gastrointestinal, and myocardial resistance.<ref>PMID:22168587</ref>
+[https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN] Defects in THRA are the cause of congenital hypothyroidism non-goitrous type 6 (CHNG6) [MIM:[https://omim.org/entry/614450 614450]. A disease characterized by growth retardation, developmental retardation, skeletal dysplasia, borderline low thyroxine levels and high triiodothyronine levels. There is differential sensitivity to thyroid hormone action, with retention of hormone responsiveness in the hypothalamic pituitary axis and liver but skeletal, gastrointestinal, and myocardial resistance.<ref>PMID:22168587</ref>
 == Function ==
-[[https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN]] Nuclear hormone receptor. High affinity receptor for triiodothyronine.
+[https://www.uniprot.org/uniprot/THA_HUMAN THA_HUMAN] Nuclear hormone receptor. High affinity receptor for triiodothyronine.
 <div style="background-color:#fffaf0;">
 == Publication Abstract from PubMed ==
@@ Line 20: / Line 21: @@
 </div>
 <div class="pdbe-citations 7qdt" style="background-color:#fffaf0;"></div>
+==See Also==
+*[[Thyroid hormone receptor|Thyroid hormone receptor]]
 == References ==
 <references/>
 __TOC__
 </StructureSection>
+[[Category: Homo sapiens]]
 [[Category: Large Structures]]
-[[Category: Agostini, M]]
+[[Category: Agostini M]]
-[[Category: Chatterjee, K]]
+[[Category: Chatterjee K]]
-[[Category: Fairall, L]]
+[[Category: Fairall L]]
-[[Category: Romartinez-Alonso, B]]
+[[Category: Romartinez-Alonso B]]
-[[Category: Schwabe, J]]
+[[Category: Schwabe J]]
-[[Category: Mutation]]
-[[Category: Nuclear protein]]
-[[Category: Nuclear receptor]]
-[[Category: Thyroid hormone]]

7qdt

From Proteopedia

Revision as of 11:06, 15 November 2023

Crystal structure of a mutant (P393GX) Thyroid Receptor Alpha ligand binding domain designed to model dominant negative human mutations.

Structural highlights

Disease

Function

Publication Abstract from PubMed

See Also

References

Contents

Proteopedia Page Contributors and Editors (what is this?)

Views

Personal tools

Navigation

Search

Toolbox